Published in J Virol on February 01, 1991
The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J (2001) 3.80
Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol (2000) 3.20
DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci U S A (1997) 3.03
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest (2007) 2.80
The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol (1991) 2.42
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology (2009) 2.20
Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci U S A (1994) 2.12
Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc Natl Acad Sci U S A (1998) 1.83
Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci U S A (1995) 1.80
Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol Cell Biol (1994) 1.74
Dynamic analysis of proviral induction and De Novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression. Mol Cell Biol (2000) 1.67
The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites. J Virol (2000) 1.60
Retrovirus-mediated insertion of expressed and non-expressed genes at identical chromosomal locations. Nucleic Acids Res (1993) 1.55
Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. J Virol (1998) 1.42
Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol (1997) 1.22
Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation. J Virol (2003) 1.15
Chromatin, gene silencing and HIV latency. Genome Biol (2007) 1.01
Demethylation of somatic and testis-specific histone H2A and H2B genes in F9 embryonal carcinoma cells. Mol Cell Biol (1993) 0.93
The core element of a CpG island protects avian sarcoma and leukosis virus-derived vectors from transcriptional silencing. J Virol (2008) 0.92
Human beta interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to a retroviral vector. J Virol (2000) 0.92
Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site. J Virol (1996) 0.89
Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning. Mol Ther (2011) 0.88
Lack of correlation between basal expression levels and susceptibility to transcriptional shutdown among single-gene murine leukemia virus vector proviruses. J Virol (1994) 0.88
Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy. J Virol (1997) 0.86
A correlation between dexamethasone inducibility and basal expression levels of retroviral vector proviruses. Nucleic Acids Res (1993) 0.86
Specific in vivo expression in type II pneumocytes of the Jaagsiekte sheep retrovirus long terminal repeat in transgenic mice. Virology (2007) 0.82
Locus control region of the human CD2 gene in a lentivirus vector confers position-independent transgene expression. J Virol (2001) 0.82
Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma -chain and multidrug resistance (MDR1) transgenes in canine bone marrow. Proc Natl Acad Sci U S A (2002) 0.80
Epigenetic changes of lentiviral transgenes in porcine stem cells derived from embryonic origin. PLoS One (2013) 0.79
DNA methylation of helper virus increases genetic instability of retroviral vector producer cells. J Virol (2000) 0.78
Reactivation of Silenced WT1 Transgene by Hypomethylating Agents - Implications for in vitro Modeling of Chemoimmunotherapy. Immune Netw (2012) 0.77
Human growth hormone (hGH) secretion in milk of goats after direct transfer of the hGH gene into the mammary gland by using replication-defective retrovirus vectors. Proc Natl Acad Sci U S A (1994) 0.77
Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy. Viruses (2014) 0.77
Dynamics and evolution of β-catenin-dependent Wnt signaling revealed through massively parallel clonogenic screening. Integr Biol (Camb) (2014) 0.77
Chimeric retroviral helper virus and picornavirus IRES sequence to eliminate DNA methylation for improved retroviral packaging cells. J Virol (2000) 0.77
An Erythroid-Specific Chromatin Opening Element Increases β-Globin Gene Expression from Integrated Retroviral Gene Transfer Vectors. Gene Ther Mol Biol (2004) 0.75
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Nucleotide sequence of Moloney murine leukaemia virus. Nature (1981) 24.82
Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell (1987) 15.79
Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J (1986) 11.41
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1987) 7.91
Negative regulation of viral enhancers in undifferentiated embryonic stem cells. Cell (1985) 5.88
Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cells. Nature (1984) 4.52
Chromosomal position and activation of retroviral genomes inserted into the germ line of mice. Cell (1981) 4.42
Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell (1986) 4.32
Highly preferred targets for retrovirus integration. Cell (1988) 3.89
UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol Cell Biol (1989) 3.83
DNA methylation and gene expression: endogenous retroviral genome becomes infectious after molecular cloning. Proc Natl Acad Sci U S A (1981) 3.70
Human CD2 3'-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell (1989) 3.48
Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J Virol (1987) 3.45
Retrovirus genomes methylated by mammalian but not bacterial methylase are non-infectious. Nature (1983) 3.43
Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin. J Virol (1986) 3.21
Independent mechanisms involved in suppression of the Moloney leukemia virus genome during differentiation of murine teratocarcinoma cells. Cell (1983) 3.06
Delayed de novo methylation in teratocarcinoma suggests additional tissue-specific mechanisms for controlling gene expression. Nature (1983) 2.86
Infectivity and methylation of retroviral genomes is correlated with expression in the animal. Cell (1981) 2.73
Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo. Proc Natl Acad Sci U S A (1986) 2.69
Transcriptionally active genome regions are preferred targets for retrovirus integration. J Virol (1990) 2.59
Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo. J Virol (1988) 2.55
Expression of a retrovirus encoding human HPRT in mice. Science (1984) 2.48
Progress toward human gene therapy. Science (1989) 2.26
Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells. Mol Cell Biol (1989) 2.20
The primary structure of the alpha subunit of human elongation factor 1. Structural aspects of guanine-nucleotide-binding sites. Eur J Biochem (1986) 2.12
DNA methylation. The effect of minor bases on DNA-protein interactions. Biochem J (1990) 2.09
Factors affecting long-term stability of Moloney murine leukemia virus-based vectors. Virology (1989) 1.97
Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells. J Virol (1987) 1.90
Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays. J Virol (1989) 1.84
Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions. J Virol (1990) 1.84
Proviral sequences that restrict retroviral expression in mouse embryonal carcinoma cells. Mol Cell Biol (1987) 1.84
Cloning of two genetically transmitted Moloney leukemia proviral genomes: correlation between biological activity of the cloned DNA and viral genome activation in the animal. J Virol (1982) 1.83
Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic retroviruses. Mol Cell Biol (1987) 1.73
Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc Natl Acad Sci U S A (1987) 1.68
Retroviral mutants efficiently expressed in embryonal carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.60
Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia. Cancer Res (1970) 1.56
Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 1.49
Methylation, expression and chromosomal position of genes in mammals. Biochim Biophys Acta (1984) 1.49
Tissue-specific and ectopic expression of genes introduced into transgenic mice by retroviruses. Science (1986) 1.38
Expression of human adenosine deaminase in murine hematopoietic cells. Mol Cell Biol (1988) 1.35
Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrow. Blood (1990) 1.35
Negative regulation of retrovirus expression in embryonal carcinoma cells mediated by an intragenic domain. J Virol (1988) 1.24
A cellular enhancer of retrovirus gene expression in embryonal carcinoma cells. Proc Natl Acad Sci U S A (1987) 1.18
Human adenosine deaminase expression in mice. Blood (1990) 1.07
Suppression of the hypomethylated Moloney leukemia virus genome in undifferentiated teratocarcinoma cells and inefficiency of transformation by a bacterial gene under control of the long terminal repeat. Mol Cell Biol (1985) 1.07
Clonal variants of differentiated P19 embryonal carcinoma cells exhibit epidermal growth factor receptor kinase activity. Dev Biol (1985) 1.01
Methylation state and DNase I sensitivity of chromatin containing Moloney murine leukemia virus DNA in exogenously infected mouse cells. J Virol (1982) 0.94
Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer. J Biol Chem (1990) 0.91
Retrovirus-mediated gene transfer into embryonal carcinoma and hemopoietic stem cells: expression from a hybrid long terminal repeat. Gene (1989) 0.86
Stability of retrovirally transduced markers in a rat cell line. Somat Cell Mol Genet (1986) 0.77
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA. Virology (1980) 5.86
Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature (1983) 5.40
Transformation of rat cells by DNA of human adenovirus 5. Virology (1973) 4.85
A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene (1986) 4.43
Assay of transforming activity of tumor virus DNA. Methods Enzymol (1980) 4.31
The 2.2 kb E1b mRNA of human Ad12 and Ad5 codes for two tumor antigens starting at different AUG triplets. Cell (1981) 4.16
MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J (1996) 4.13
Adenosine deaminase: characterization and expression of a gene with a remarkable promoter. EMBO J (1985) 3.68
A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell (1990) 3.48
Size and location of the transforming region in human adenovirus type 5 DNA. Nature (1974) 3.02
Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature (1983) 2.96
Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature (1985) 2.90
Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J (1993) 2.83
The nucleotide sequence at the termini of adenovirus type 5 DNA. Nucleic Acids Res (1977) 2.61
New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther (1998) 2.37
Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J (1996) 2.31
Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep (2001) 2.27
Insulin stimulation of gene expression mediated by p21ras activation. EMBO J (1991) 2.23
Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell (1989) 2.20
Poly(A) tail shortening is the translation-dependent step in c-myc mRNA degradation. Mol Cell Biol (1990) 2.06
Chicken anemia virus causes apoptosis of thymocytes after in vivo infection and of cell lines after in vitro infection. J Virol (1992) 1.98
Comparative study of the p53-mdm2 and p53-MDMX interfaces. Oncogene (1999) 1.98
Intermediates in type 5 adenovirus DNA replication. Virology (1973) 1.96
Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization. Nucleic Acids Res (1984) 1.96
Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53. Cancer Res (2001) 1.92
IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J (1997) 1.91
A- and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes. EMBO J (1993) 1.90
The primary structure of elongation factor EF-1 alpha from the brine shrimp Artemia. EMBO J (1984) 1.86
WT1 proteins: functions in growth and differentiation. Gene (2001) 1.82
Comparison of nucleotide sequences of the early E1a regions for subgroups A, B and C of human adenoviruses. Gene (1980) 1.68
Mutations in N-ras predominate in acute myeloid leukemia. Blood (1987) 1.68
Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor family. Mol Cell Biol (1990) 1.66
Nucleotide sequence of the Agrobacterium tumefaciens octopine Ti plasmid-encoded tmr gene. Nucleic Acids Res (1983) 1.64
Structural properties of adenovirus DNA's. Biochim Biophys Acta (1969) 1.60
Structure and function of the transforming genes of human adenoviruses and SV40. Cold Spring Harb Symp Quant Biol (1980) 1.60
Correction of xeroderma pigmentosum repair defect by basal transcription factor BTF2 (TFIIH). EMBO J (1994) 1.60
Sequence specificity of the wild-type dam+) and mutant (damh) forms of bacteriophage T2 DNA adenine methylase. J Mol Biol (1978) 1.58
The structure and function of the regulatory elements of the Escherichia coli uvrB gene. Nucleic Acids Res (1981) 1.58
Molecular cloning and biological characterization of the human excision repair gene ERCC-3. Mol Cell Biol (1990) 1.57
Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. Genes Dev (1998) 1.42
Post-transcriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells. Science (1987) 1.42
Role of the adenovirus early region 1B tumor antigens in transformation and lytic infection. Virology (1986) 1.38
The nucleotide sequence of adenovirus type 5 early region E1: the region between map positions 8.0 (HindIII site) and 11.8 (SmaI site). Gene (1980) 1.38
Isolation and identification of the human homolog of a new p53-binding protein, Mdmx. Genomics (1997) 1.37
Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res (1995) 1.36
In vitro synthesis of adenovirus type 5 T antigens. I. Translation of early region 1-specific rna from lytically infected cells. J Virol (1981) 1.35
The nucleotide sequence of the transforming early region E1 of adenovirus type 5 DNA. Gene (1980) 1.33
A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene. Nucleic Acids Res (1986) 1.33
Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene. Nucleic Acids Res (1987) 1.31
The repression of the growth factor-inducible genes JE, c-myc and stromelysin by adenovirus E1A is mediated by conserved region 1. Oncogene (1989) 1.26
Deletion mutants of region E1a of AD12 E1 plasmids: effect on oncogenic transformation. Virology (1983) 1.26
Methylated oligonucleotides derived from bacteriophage fd RF-DNA modified in vitro by E. coli B modification methylase. FEBS Lett (1973) 1.25
The nucleotide sequence of the gene for protein IVa2 and of the 5' leader segment of the major late mRNAs of adenovirus type 5. Gene (1981) 1.24
Isolation of cDNA clones for human adenosine deaminase. Gene (1983) 1.24
Transformation of primary rat kidney cells by fragments of simian virus 40 DNA. J Virol (1975) 1.22
Morphological transformation of human adenoviruses is determined to a large extent by gene products of region E1a. Virology (1983) 1.22
Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein. Nucleic Acids Res (1984) 1.22
Immunogenic and protective properties of chicken anaemia virus proteins expressed by baculovirus. Vaccine (1995) 1.20
The first exon of region E1a genes of adenoviruses 5 and 12 encodes a separate functional protein domain. EMBO J (1984) 1.17
Activation of adenovirus 5 E1A transcription by region E1B in transformed primary rat cells. EMBO J (1987) 1.17
Adenovirus E1A-mediated regulation of class I MHC expression. EMBO J (1986) 1.16
Cloning of human adenosine deaminase cDNA and expression in mouse cells. Gene (1984) 1.16
Transfection of human lymphoblastoid cells with herpes simplex viral DNA. Proc Natl Acad Sci U S A (1979) 1.15
Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells. EMBO J (1990) 1.12
Nucleotide sequences of adenovirus DNAs. Curr Top Microbiol Immunol (1984) 1.11
How phosphorylation regulates the activity of p53. J Mol Biol (1996) 1.10
Adenovirus E1A proteins inhibit activation of transcription by p53. Mol Cell Biol (1996) 1.09
One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity. EMBO J (1986) 1.09
An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene. J Immunol (1995) 1.08
Mutational analysis of ERCC3, which is involved in DNA repair and transcription initiation: identification of domains essential for the DNA repair function. Mol Cell Biol (1994) 1.08
Naturally occurring BK virus variants (JL and Dik) with deletions in the putative early enhancer-promoter sequences. J Virol (1985) 1.08
Introduction of sequences encoding functional human adenosine deaminase into mouse cells using a retroviral shuttle system. Gene (1985) 1.07
Rapid c-myc mRNA degradation does not require (A + U)-rich sequences or complete translation of the mRNA. Nucleic Acids Res (1991) 1.06
Specific tumor-cell killing with adenovirus vectors containing the apoptin gene. Gene Ther (1999) 1.06
Differential sensitivity to Ad5 E1B-21kD and Bcl-2 proteins of apoptin-induced versus p53-induced apoptosis. Carcinogenesis (1995) 1.05
Identification and mapping of the early gene products of adenovirus type 12. Virology (1980) 1.03
The adenovirus E1A-associated 300 kDa adaptor protein counteracts the inhibition of the collagenase promoter by E1A and represses transformation. Oncogene (1996) 1.03
The xeroderma pigmentosum group B protein ERCC3 produced in the baculovirus system exhibits DNA helicase activity. Nucleic Acids Res (1994) 1.01
Analysis of polyadenylation site usage of the c-myc oncogene. Nucleic Acids Res (1989) 1.00
Expression of human adenosine deaminase in mice transplanted with hemopoietic stem cells infected with amphotropic retroviruses. J Exp Med (1990) 1.00
Apoptin, a protein encoded by chicken anemia virus, induces cell death in various human hematologic malignant cells in vitro. Leukemia (1995) 1.00
Analysis of the rat JE gene promoter identifies an AP-1 binding site essential for basal expression but not for TPA induction. Nucleic Acids Res (1990) 1.00
Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway. Mol Cell Biol (1989) 0.99
Similar effects of adenovirus E1A and glucocorticoid hormones on the expression of the metalloprotease stromelysin. Nucleic Acids Res (1988) 0.99
EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Oncogene (2000) 0.99